RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
$86.41
-1.34%
-1.17
Notify me if price changes either direction
Buy RYTM stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
5.9B
Enterprise value
5.9B
Trailing PE
-27.787780761719
Forward PE
-110.28866
PEG Ratio
-11.254051208496
Enterprise to EBITDA
-30.028
Enterprise to revenue
27.125
Price to book MRQ
42.344128
Price to sales TTM
27.672432
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
217.2M
EBITDA
-196166000
Diluted EPS TTM
-3.13
Total Cash (MRQ)
340.6M
Current ratio (MRQ)
4.168
Operating Cash Flow (TTM)
-119509000
RYTM trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
